Market Overview The retinoblastoma treatment market is revolutionizing as genetic screening and early detection transform treatment outcomes through proactive surveillance. The Retinoblastoma Treatment Market is projected to grow through 2030, driven by RB1 mutation identification, newborn screening expansion, and familial surveillance programs enabling earliest possible intervention. Current...